| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
NanoString Technologies Inc (F: 0F1)
0F1 Technical Analysis
5
| As on 11th Jul 2023 0F1 STOCK Price closed @ 3.94 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 16.60 & Strong Sell for SHORT-TERM with Stoploss of 30.25 we also expect STOCK to react on Following IMPORTANT LEVELS. |
0F1STOCK Price
| Open | 3.94 | Change | Price | % |
| High | 3.94 | 1 Day | 0.60 | 17.96 |
| Low | 3.94 | 1 Week | 0.32 | 8.84 |
| Close | 3.94 | 1 Month | -1.46 | -27.04 |
| Volume | 400 | 1 Year | -25.46 | -86.60 |
| 52 Week High 33.80 | 52 Week Low 3.24 | ||||
F Germany Most Active Stocks
| ENB | 47.60 | -0.92% |
| TEF | 3.84 | -0.52% |
| TEF | 3.84 | -0.52% |
| WHL | 5150.00 | -0.44% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
| TOE | 0.02 | 0.00% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
| 0F1 Daily Charts |
0F1 Intraday Charts |
Whats New @ Bazaartrend |
0F1 Free Analysis |
|
|
0F1 Important Levels Intraday
| RESISTANCE | 3.94 |
| RESISTANCE | 3.94 |
| RESISTANCE | 3.94 |
| RESISTANCE | 3.94 |
| RESISTANCE | 3.94 |
| RESISTANCE | 3.94 |
| RESISTANCE | 3.94 |
| RESISTANCE | 3.94 |
0F1 Forecast May 2024
| 4th UP Forecast | 20.13 |
| 3rd UP Forecast | 14.94 |
| 2nd UP Forecast | 11.73 |
| 1st UP Forecast | 8.52 |
| 1st DOWN Forecast | -0.64 |
| 2nd DOWN Forecast | -3.85 |
| 3rd DOWN Forecast | -7.06 |
| 4th DOWN Forecast | -12.25 |
0F1 Weekly Forecast
| 4th UP Forecast | 10.88 |
| 3rd UP Forecast | 8.65 |
| 2nd UP Forecast | 7.28 |
| 1st UP Forecast | 5.90 |
| 1st DOWN Forecast | 1.98 |
| 2nd DOWN Forecast | 0.60 |
| 3rd DOWN Forecast | -0.77 |
| 4th DOWN Forecast | -3.00 |
0F1 Forecast2024
| 4th UP Forecast | 62.83 |
| 3rd UP Forecast | 43.94 |
| 2nd UP Forecast | 32.27 |
| 1st UP Forecast | 20.6 |
| 1st DOWN Forecast | -12.72 |
| 2nd DOWN Forecast | -24.39 |
| 3rd DOWN Forecast | -36.06 |
| 4th DOWN Forecast | -54.95 |
NanoString Technologies Inc ( F Germany Symbol : 0F1 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
0F1 Business Profile
NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers nCounter based reagents that allow users to design customized assays; Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics; and Hyb & Seq technologies. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was founded in 2003 and is headquartered in Seattle, Washington. Address: 530 Fairview Avenue North, Seattle, WA, United States, 98109
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service